help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 9, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1417
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/12/4747    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, I. J.
Right arrow Articles by Barden, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, I. J.
Right arrow Articles by Barden, A.

Submitted on June 26, 2007
Accepted on September 27, 2007

IMPAIRED EX-VIVO LEUKOTRIENE B4 PRODUCTION CHARACTERIZES THE METABOLIC SYNDROME AND IS IMPROVED AFTER WEIGHT REDUCTION

I. J. Tsai, L. J. Beilin, I. B. Puddey, K. D. Croft, and A. Barden*

University of Western Australia, School of Medicine and Pharmacology, Royal Perth Hospital, Western Australia, Australia

* To whom correspondence should be addressed. E-mail: anne.barden{at}uwa.edu.au.

Context: Neutrophil (PMN) production of leukotriene B4 (LTB4), may be associated with alterations in immune and inflammatory function that characterize the metabolic syndrome (MetS).

Objective: We investigated whether PMN production of LTB4 and its metabolites 20-OH-LTB4 and 20-COOH-LTB4 were altered in subjects with features of the MetS before and after weight reduction.

Design, Setting, Patients, and Intervention: In a case-controlled comparison, men and postmenopausal women with features of the MetS were matched with controls. Subjects with MetS were then matched and randomly assigned to either a 12-wk weight reduction study followed by 4-wk weight stabilization or 16 wk of weight maintenance.

Main Outcome Measures: Measurements were performed at baseline and the end of the 16-wk period. Stimulated neutrophil LTB4 and its metabolites were measured by HPLC.

Results: In the case-controlled study, BMI, waist circumference, blood pressure, fasting triglycerides and glucose were all significantly raised in subjects with features of the MetS (P < 0.05). Production of LTB4 and 20-OH-LTB4 was significantly lower compared with controls (P < 0.005). The weight loss intervention resulted in a 4.6-kg reduction in body weight and 6.6-cm decrease in waist circumference relative to controls and a significant increase in LTB4 and 20-OH- LTB4.

Conclusion: Subjects with features of the MetS have lower stimulated LTB4, which is not due to increased metabolism of LTB4. Weight reduction restored the production of neutrophil LTB4, suggesting that as well as modifying cardiovascular risk, weight loss may also help with the management of perturbed inflammatory responses in overweight subjects.


Key words: leukotriene B4 • metabolic syndrome • weight loss







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society